Sumati Rao
Impact in
- Oncology top 10%
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
- Cutaneous Melanoma Detection and Management
- Rheumatology top 10%
- Spondyloarthritis Studies and Treatments
Papers in
- Oncology 26
- Cancer Immunotherapy and Biomarkers 17
- CAR-T cell therapy research 15
- Cutaneous Melanoma Detection and Management 8
-
- Melanoma and MAPK Pathways 8
- Co-authors
- Ahmad A. Tarhini (11 shared papers)Komal Gupte-Singh (13 shared papers)David F. McDermott (12 shared papers)Corey Ritchings (11 shared papers)Michael B. Atkins (9 shared papers)Vibeke Strand (1 shared paper)Eric Ruderman (1 shared paper)Alicia C. Shillington (1 shared paper)
- Journals
- Journal of Clinical Oncology (11 papers)Future Oncology (3 papers)PLoS ONE (2 papers)Cancer Research (1 paper)Arthritis Care & Research (1 paper)
- Partner nations
- United StatesUnited KingdomGermany
In The Last Decade
Sumati Rao
40 papers receiving 553 citations
Peers
Comparison fields: 5 of 70
- Oncology 316
- Rheumatology 85
- Pulmonary and Respiratory Medicine 163
- Nephrology 34
- Immunology 93
Countries citing papers authored by Sumati Rao
This map shows the geographic impact of Sumati Rao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sumati Rao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sumati Rao more than expected).
Fields of papers citing papers by Sumati Rao
This network shows the impact of papers produced by Sumati Rao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sumati Rao. The network helps show where Sumati Rao may publish in the future.
Co-authors
The 25 scholars most cited alongside Sumati Rao, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 42 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 88 | |
| 2 | 2013 | 84 | |
| 3 | 2019 | 58 | |
| 4 | 2000 | 40 | |
| 5 | 2019 | 39 | |
| 6 | 2019 | 25 | |
| 7 | 2018 | 23 | |
| 8 | 2018 | 20 | |
| 9 | 2020 | 18 | |
| 10 | 2019 | 15 | |
| 11 | 2021 | 14 | |
| 12 | 2018 | 14 | |
| 13 | 2019 | 14 | |
| 14 | 2020 | 12 | |
| 15 | 2020 | 12 | |
| 16 | 2015 | 11 | |
| 17 | 2024 | 11 | |
| 18 | 2019 | 9 | |
| 19 | 2012 | 7 | |
| 20 | 2019 | 6 |
About Sumati Rao
Sumati Rao is a scholar working on Oncology, Molecular Biology, Pulmonary and Respiratory Medicine, Economics and Econometrics and Genetics, having authored 42 papers that have together received 566 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (17 papers), CAR-T cell therapy research (15 papers), Cutaneous Melanoma Detection and Management (8 papers), Melanoma and MAPK Pathways (8 papers), Health Systems, Economic Evaluations, Quality of Life (7 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (5 papers), Economic and Financial Impacts of Cancer (5 papers) and Renal cell carcinoma treatment (5 papers). The work is most often cited by research in Oncology (316 citations), Rheumatology (85 citations), Pulmonary and Respiratory Medicine (163 citations), Nephrology (34 citations) and Immunology (93 citations). Sumati Rao has collaborated with scholars based in United States, United Kingdom and Germany. Frequent co-authors include Ahmad A. Tarhini, Komal Gupte-Singh, David F. McDermott, Corey Ritchings, Michael B. Atkins, Vibeke Strand, Eric Ruderman, Alicia C. Shillington, Mary Cifaldi and Keith A. Betts. Their work appears in journals such as Journal of Clinical Oncology, Future Oncology, PLoS ONE, Cancer Research and Arthritis Care & Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.